| Published Application/Species/Sample/Dilution | Reference |
|---|
- immunocytochemistry; human; loading ...; fig 2b
- western blot; human; loading ...; fig 1b
| Lim J, Kim H, Nguyen K, Cho K. The role of TLR9 in stress-dependent autophagy formation. Biochem Biophys Res Commun. 2016;481:219-226 pubmed publisher |
- immunohistochemistry; mouse; 1:150; loading ...; fig 3i
- western blot; mouse; 1:150; loading ...; fig s1
- immunohistochemistry; human; 1:150; loading ...; fig 2i
- western blot; human; 1:150; loading ...; fig s1
| Huhta H, Helminen O, Kauppila J, Salo T, Porvari K, Saarnio J, et al. The Expression of Toll-like Receptors in Normal Human and Murine Gastrointestinal Organs and the Effect of Microbiome and Cancer. J Histochem Cytochem. 2016;64:470-82 pubmed publisher |
- immunocytochemistry; mouse; 1:250; fig s5
| Acharya M, Sokolovska A, Tam J, Conway K, Stefani C, Raso F, et al. αv Integrins combine with LC3 and atg5 to regulate Toll-like receptor signalling in B cells. Nat Commun. 2016;7:10917 pubmed publisher |
- immunoprecipitation; human
- western blot; human
| Saito K, Kukita K, Kutomi G, Okuya K, Asanuma H, Tabeya T, et al. Heat shock protein 90 associates with Toll-like receptors 7/9 and mediates self-nucleic acid recognition in SLE. Eur J Immunol. 2015;45:2028-41 pubmed publisher |
- immunohistochemistry - paraffin section; human
| Huhta H, Helminen O, Kauppila J, Takala H, Metsikkö K, Lehenkari P, et al. Toll-like receptor 9 expression in the natural history of Barrett mucosa. Virchows Arch. 2015;467:9-18 pubmed publisher |
- immunohistochemistry - paraffin section; human
| Kauppila J, Korvala J, Siirilä K, Manni M, Mäkinen L, Hagstrom J, et al. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue. J Oral Pathol Med. 2015;44:571-7 pubmed publisher |
| Bharti D, Kumar A, Mahla R, Kumar S, Ingle H, Shankar H, et al. The role of TLR9 polymorphism in susceptibility to pulmonary tuberculosis. Immunogenetics. 2014;66:675-81 pubmed publisher |
- immunohistochemistry - paraffin section; human
| Fehri E, Ennaifer E, Ardhaoui M, Ouerhani K, Laassili T, Bel Haj Rhouma R, et al. Expression of Toll-like receptor 9 increases with progression of cervical neoplasia in Tunisian women--a comparative analysis of condyloma, cervical intraepithelial neoplasia and invasive carcinoma. Asian Pac J Cancer Prev. 2014;15:6145-50 pubmed |
- immunohistochemistry - paraffin section; human
- immunocytochemistry; human
| Tengroth L, Millrud C, Kvarnhammar A, Kumlien Georén S, Latif L, Cardell L. Functional effects of Toll-like receptor (TLR)3, 7, 9, RIG-I and MDA-5 stimulation in nasal epithelial cells. PLoS ONE. 2014;9:e98239 pubmed publisher |
| Ruan M, Thorn K, Liu S, Li S, Yang W, Zhang C, et al. The secretion of IL-6 by CpG-ODN-treated cancer cells promotes T-cell immune responses partly through the TLR-9/AP-1 pathway in oral squamous cell carcinoma. Int J Oncol. 2014;44:2103-10 pubmed publisher |
| Ruan M, Zhang Z, Li S, Yan M, Liu S, Yang W, et al. Activation of Toll-like receptor-9 promotes cellular migration via up-regulating MMP-2 expression in oral squamous cell carcinoma. PLoS ONE. 2014;9:e92748 pubmed publisher |
- immunocytochemistry; mouse
| Veselits M, Tanaka A, Lipkowitz S, O Neill S, Sciammas R, Finnegan A, et al. Recruitment of Cbl-b to B cell antigen receptor couples antigen recognition to Toll-like receptor 9 activation in late endosomes. PLoS ONE. 2014;9:e89792 pubmed publisher |
- immunocytochemistry; human
| Zufferey A, Schvartz D, Nolli S, Reny J, Sanchez J, Fontana P. Characterization of the platelet granule proteome: evidence of the presence of MHC1 in alpha-granules. J Proteomics. 2014;101:130-40 pubmed publisher |
- immunohistochemistry - paraffin section; human
- western blot; human
| Korvala J, Harjula T, Siirilä K, Almangush A, Aro K, Makitie A, et al. Toll-like receptor 9 expression in mucoepidermoid salivary gland carcinoma may associate with good prognosis. J Oral Pathol Med. 2014;43:530-7 pubmed publisher |
- immunocytochemistry; human
| Hamidi S, Schäfer Korting M, Weindl G. TLR2/1 and sphingosine 1-phosphate modulate inflammation, myofibroblast differentiation and cell migration in fibroblasts. Biochim Biophys Acta. 2014;1841:484-94 pubmed publisher |
- immunocytochemistry; human
- western blot; human
| Sathe A, Reddy K. TLR9 and RIG-I signaling in human endocervical epithelial cells modulates inflammatory responses of macrophages and dendritic cells in vitro. PLoS ONE. 2014;9:e83882 pubmed publisher |
| Chandel H, Pandey S, Shukla D, Lalsare K, Selvaraj S, Jha M, et al. Toll-like receptors and CD40 modulate each other's expression affecting Leishmania major infection. Clin Exp Immunol. 2014;176:283-90 pubmed publisher |
| Hiltunen N, Kemi N, V xe4 yrynen J, B xf6 hm J, Kauppila J, Huhta H, et al. Toll-like receptors 1-9 in small bowel neuroendocrine tumors-Clinical significance and prognosis. PLoS ONE. 2024;19:e0302813 pubmed publisher |
| Ramini D, Giuliani A, Kwiatkowska K, Guescini M, Storci G, Mens xe0 E, et al. Replicative senescence and high glucose induce the accrual of self-derived cytosolic nucleic acids in human endothelial cells. Cell Death Discov. 2024;10:184 pubmed publisher |
| Oh T, Kang G, Jo H, Park H, Lee Y, Ahn G. DNA-dependent protein kinase regulates cytosolic double-stranded DNA secretion from irradiated macrophages to increase radiosensitivity of tumors. Radiother Oncol. 2024;193:110111 pubmed publisher |
| Ni H, Wang Y, Yao K, Wang L, HUANG J, Xiao Y, et al. Cyclical palmitoylation regulates TLR9 signalling and systemic autoimmunity in mice. Nat Commun. 2024;15:1 pubmed publisher |
| Tripathi A, Bartosh A, Whitehead C, Pillai A. Activation of cell-free mtDNA-TLR9 signaling mediates chronic stress-induced social behavior deficits. Mol Psychiatry. 2023;28:3806-3815 pubmed publisher |
| Spurgeon B, Frelinger A. Platelet Phenotyping by Full Spectrum Flow Cytometry. Curr Protoc. 2023;3:e687 pubmed publisher |
| Meng Y, Ma J, Yao C, Ye Z, Ding H, Liu C, et al. The NCF1 variant p.R90H aggravates autoimmunity by facilitating the activation of plasmacytoid dendritic cells. J Clin Invest. 2022;132: pubmed publisher |
| Lam L, Dobkin J, Eckart K, Gereg I, DiSalvo A, Nolder A, et al. Bat Red Blood Cells Express Nucleic Acid-Sensing Receptors and Bind RNA and DNA. Immunohorizons. 2022;6:299-306 pubmed publisher |
| Yu J, Kim J, Nam K, Lee W, Rhee D. Pneumococcal Δpep27 Immunization Attenuates TLRs and NLRP3 Expression and Relieves Murine Ovalbumin-Induced Allergic Rhinitis. J Microbiol Biotechnol. 2022;32:709-717 pubmed publisher |
| Ma X, Rawnsley D, Kovacs A, Islam M, Murphy J, Zhao C, et al. TRAF2, an Innate Immune Sensor, Reciprocally Regulates Mitophagy and Inflammation to Maintain Cardiac Myocyte Homeostasis. JACC Basic Transl Sci. 2022;7:223-243 pubmed publisher |
| Li Z, Fu W, Chen X, Wang S, Deng R, Tang X, et al. Autophagy-based unconventional secretion of HMGB1 in glioblastoma promotes chemosensitivity to temozolomide through macrophage M1-like polarization. J Exp Clin Cancer Res. 2022;41:74 pubmed publisher |
| Branchi V, Esser L, Boden C, Jafari A, Henn J, Lingohr P, et al. A Combined TLR7/TLR9/GATA3 Score Can Predict Prognosis in Biliary Tract Cancer. Diagnostics (Basel). 2021;11: pubmed publisher |
| Khin P, Hong Y, Yeon M, Lee D, Lee J, Jun H. Dulaglutide improves muscle function by attenuating inflammation through OPA-1-TLR-9 signaling in aged mice. Aging (Albany NY). 2021;13:21962-21974 pubmed publisher |
| Ishizu T, Eichin D, Padzik A, Tuominen S, Grenman R, Salmi M, et al. Head and neck squamous cell carcinoma cell lines have an immunomodulatory effect on macrophages independent of hypoxia and toll-like receptor 9. BMC Cancer. 2021;21:990 pubmed publisher |
| Kuramoto K, Kim Y, Hong J, He C. The autophagy protein Becn1 improves insulin sensitivity by promoting adiponectin secretion via exocyst binding. Cell Rep. 2021;35:109184 pubmed publisher |
| Li F, Surolia R, Li H, Wang Z, Liu G, Kulkarni T, et al. Citrullinated vimentin mediates development and progression of lung fibrosis. Sci Transl Med. 2021;13: pubmed publisher |
| Niemczyk G, Fus L, Czarzasta K, Jesion A, Radziszewski P, Gornicka B, et al. Expression of Toll-Like Receptors in the Animal Model of Bladder Outlet Obstruction. Biomed Res Int. 2020;2020:6632359 pubmed publisher |
| Korimová A, Dubovy P. N-Formylated Peptide Induces Increased Expression of Both Formyl Peptide Receptor 2 (Fpr2) and Toll-Like Receptor 9 (TLR9) in Schwannoma Cells-An In Vitro Model for Early Inflammatory Profiling of Schwann Cells. Cells. 2020;9: pubmed publisher |
| Wang C, Chen C, Lin M, Su H, Ho M, Yeh J, et al. TLR9 Binding to Beclin 1 and Mitochondrial SIRT3 by a Sodium-Glucose Co-Transporter 2 Inhibitor Protects the Heart from Doxorubicin Toxicity. Biology (Basel). 2020;9: pubmed publisher |
| Richard Albert J, Au Yeung W, Toriyama K, Kobayashi H, Hirasawa R, Brind Amour J, et al. Maternal DNMT3A-dependent de novo methylation of the paternal genome inhibits gene expression in the early embryo. Nat Commun. 2020;11:5417 pubmed publisher |
| Natarajan S, Ranganathan M. Toll-like receptor (TLR) gene expression and immunostimulatory effect of CpG oligonucleotides in hormone receptor positive cell line T47D and triple negative breast cancer cell line MDA-MB-468. Immunopharmacol Immunotoxicol. 2020;42:408-415 pubmed publisher |
| Zhou B, Yan J, Guo L, Zhang B, Liu S, Yu M, et al. Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma. Theranostics. 2020;10:6530-6543 pubmed publisher |
| Du X, Ge W, Jing R, Pan L. Necroptosis in pulmonary macrophages mediates lipopolysaccharide-induced lung inflammatory injury by activating ZBP-1. Int Immunopharmacol. 2019;77:105944 pubmed publisher |
| Kalantari E, Abolhasani M, Roudi R, Farajollahi M, Farhad S, Madjd Z, et al. Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer. Int J Exp Pathol. 2019;100:123-132 pubmed publisher |
| Takahara M, Nagato T, Nozaki Y, Kumai T, Katada A, Hayashi T, et al. A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy. Cell Immunol. 2019;341:103925 pubmed publisher |
| Kapelouzou A, Kontogiannis C, Tsilimigras D, Georgiopoulos G, Kaklamanis L, Tsourelis L, et al. Differential expression patterns of Toll Like Receptors and Interleukin-37 between calcific aortic and mitral valve cusps in humans. Cytokine. 2019;116:150-160 pubmed publisher |
| Leppänen J, Helminen O, Huhta H, Kauppila J, Isohookana J, Haapasaari K, et al. Toll-like receptors 2, 4 and 9 and hypoxia markers HIF-1alpha and CAIX in pancreatic intraepithelial neoplasia. APMIS. 2018;126:852-863 pubmed publisher |
| Nie H, Mei Z, Wang R, Zhao B, Gao Y, Chen J, et al. Bushen recipe and its disassembled prescriptions inhibit inflammation of liver injury associated with Concanavalin A through Toll‑like receptor 3/9 signaling pathway. Mol Med Rep. 2018;18:1682-1691 pubmed publisher |
| Yang J, Snijders M, Haasnoot G, van Kooten C, Mallat M, de Fijter J, et al. Elevated intragraft expression of innate immunity and cell death-related markers is a risk factor for adverse graft outcome. Transpl Immunol. 2018;48:39-46 pubmed publisher |
| Chandler M, Keene K, Tuomela J, Forero Torres A, Desmond R, Vuopala K, et al. Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans. PLoS ONE. 2017;12:e0183832 pubmed publisher |
| Sun Y, Xiao Q, Luo C, Zhao Y, Pu D, Zhao K, et al. High-glucose induces tau hyperphosphorylation through activation of TLR9-P38MAPK pathway. Exp Cell Res. 2017;359:312-318 pubmed publisher |
| Heftrig D, Sturm R, Oppermann E, Kontradowitz K, Jurida K, Schimunek L, et al. Impaired Surface Expression of HLA-DR, TLR2, TLR4, and TLR9 in Ex Vivo-In Vitro Stimulated Monocytes from Severely Injured Trauma Patients. Mediators Inflamm. 2017;2017:2608349 pubmed publisher |
| Larsson O, Tengroth L, Xu Y, Uddman R, Kumlien Georén S, Cardell L. Substance P represents a novel first-line defense mechanism in the nose. J Allergy Clin Immunol. 2018;141:128-136.e3 pubmed publisher |
| Leppänen J, Helminen O, Huhta H, Kauppila J, Isohookana J, Haapasaari K, et al. High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients. Virchows Arch. 2017;470:401-410 pubmed publisher |
| Helminen O, Huhta H, Kauppila J, Lehenkari P, Saarnio J, Karttunen T. Localization of nucleic acid-sensing toll-like receptors in human and mouse pancreas. APMIS. 2017;125:85-92 pubmed publisher |
| Garrison C, Lastwika K, Zhang Y, Li C, Lampe P. Proteomic Analysis, Immune Dysregulation, and Pathway Interconnections with Obesity. J Proteome Res. 2017;16:274-287 pubmed publisher |
| Mu L, Wang Y, Wang Y, Zhang H, Shang D, Tan F, et al. Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-Like Receptor 9 Expression. World Neurosurg. 2017;97:279-283 pubmed publisher |
| Burgueño J, Barba A, Eyre E, Romero C, Neunlist M, Fernández E. TLR2 and TLR9 modulate enteric nervous system inflammatory responses to lipopolysaccharide. J Neuroinflammation. 2016;13:187 pubmed publisher |
| Meseure D, Vacher S, Drak Alsibai K, Trassard M, Nicolas A, Leclère R, et al. Biopathological Significance of TLR9 Expression in Cancer Cells and Tumor Microenvironment Across Invasive Breast Carcinomas Subtypes. Cancer Microenviron. 2016;9:107-118 pubmed publisher |
| Schnerch J, Prasse A, Vlachakis D, Schuchardt K, Pechkovsky D, Goldmann T, et al. Functional Toll-Like Receptor 9 Expression and CXCR3 Ligand Release in Pulmonary Sarcoidosis. Am J Respir Cell Mol Biol. 2016;55:749-757 pubmed |
| Jeon Y, Kim C, Koh J, Chung D, Ha G. Pellino-1 confers chemoresistance in lung cancer cells by upregulating cIAP2 through Lys63-mediated polyubiquitination. Oncotarget. 2016;7:41811-41824 pubmed publisher |
| Siponen M, Bitu C, Al Samadi A, Nieminen P, Salo T. Cathepsin K expression is increased in oral lichen planus. J Oral Pathol Med. 2016;45:758-765 pubmed publisher |
| Moreira M, Costa Pereira C, Alves M, Marteleto B, Ribeiro V, Peruhype Magalhães V, et al. Vaccination against canine leishmaniosis increases the phagocytic activity, nitric oxide production and expression of cell activation/migration molecules in neutrophils and monocytes. Vet Parasitol. 2016;220:33-45 pubmed publisher |
| Evangelista M, Castro S, Alves C, Dias A, Souza V, Reis L, et al. Early IFN-? production together with decreased expression of TLR3 and TLR9 characterizes EAE development conditional on the presence of myelin. Autoimmunity. 2016;49:258-67 pubmed publisher |
| Dillmann C, Ringel C, Ringleb J, Mora J, Olesch C, Fink A, et al. S1PR4 Signaling Attenuates ILT 7 Internalization To Limit IFN-α Production by Human Plasmacytoid Dendritic Cells. J Immunol. 2016;196:1579-90 pubmed publisher |
| Duhamel M, Rodet F, Murgoci A, Desjardins R, Gagnon H, Wisztorski M, et al. The proprotein convertase PC1/3 regulates TLR9 trafficking and the associated signaling pathways. Sci Rep. 2016;6:19360 pubmed publisher |
| Mishima Y, Ishihara S, Oka A, Fukuba N, Oshima N, Sonoyama H, et al. Decreased Frequency of Intestinal Regulatory CD5+ B Cells in Colonic Inflammation. PLoS ONE. 2016;11:e0146191 pubmed publisher |
| Zambirinis C, Levie E, Nguy S, Avanzi A, Barilla R, Xu Y, et al. TLR9 ligation in pancreatic stellate cells promotes tumorigenesis. J Exp Med. 2015;212:2077-94 pubmed publisher |
| Jamin A, Dehoux L, Dossier C, Fila M, Heming N, Monteiro R, et al. Toll-like receptor 3 expression and function in childhood idiopathic nephrotic syndrome. Clin Exp Immunol. 2015;182:332-45 pubmed publisher |
| Karlsen M, Hansen T, Nordal H, Brun J, Jonsson R, Appel S. Expression of Toll-like receptor -7 and -9 in B cell subsets from patients with primary Sjögren's syndrome. PLoS ONE. 2015;10:e0120383 pubmed publisher |
| Yu S, Wong C, Szeto C, Li E, Cai Z, Tam L. Members of the receptor for advanced glycation end products axis as potential therapeutic targets in patients with lupus nephritis. Lupus. 2015;24:675-86 pubmed publisher |
| Tengroth L, Arebro J, Kumlien Geor n S, Winqvist O, Cardell L. Deprived TLR9 expression in apparently healthy nasal mucosa might trigger polyp-growth in chronic rhinosinusitis patients. PLoS ONE. 2014;9:e105618 pubmed publisher |
| Lopez M, Palmer B, Lawrence D. Naïve T cells, unconventional NK and NKT cells, and highly responsive monocyte-derived macrophages characterize human cord blood. Immunobiology. 2014;219:756-65 pubmed publisher |
| Guerrier T, Pochard P, Lahiri A, Youinou P, Pers J, Jamin C. TLR9 expressed on plasma membrane acts as a negative regulator of human B cell response. J Autoimmun. 2014;51:23-9 pubmed publisher |
| Belmont L, Rabbe N, Antoine M, Cathelin D, Guignabert C, Kurie J, et al. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer. Int J Cancer. 2014;134:765-77 pubmed publisher |
| Väisänen M, Jukkola Vuorinen A, Vuopala K, Selander K, Vaarala M. Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer. Oncol Lett. 2013;5:1659-1663 pubmed |
| Figueiredo M, Amorim I, Pinto A, Barbosa V, Pinheiro L, Deoti B, et al. Expression of Toll-like receptors 2 and 9 in cells of dog jejunum and colon naturally infected with Leishmania infantum. BMC Immunol. 2013;14:22 pubmed publisher |
| Abdi J, Mutis T, Garssen J, Redegeld F. Characterization of the Toll-like receptor expression profile in human multiple myeloma cells. PLoS ONE. 2013;8:e60671 pubmed publisher |
| Chauhan S, Singh V, Rai R, Rai M, Rai G. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation. J Clin Immunol. 2013;33:954-64 pubmed publisher |
| Schneberger D, Caldwell S, Kanthan R, Singh B. Expression of Toll-like receptor 9 in mouse and human lungs. J Anat. 2013;222:495-503 pubmed publisher |
| Hu F, Zhang L, Zheng J, Zhao L, Huang J, Shao W, et al. Spontaneous production of immunoglobulin M in human epithelial cancer cells. PLoS ONE. 2012;7:e51423 pubmed publisher |
| Harman A, Bye C, Nasr N, Sandgren K, Kim M, Mercier S, et al. Identification of lineage relationships and novel markers of blood and skin human dendritic cells. J Immunol. 2013;190:66-79 pubmed publisher |
| Kauppila J, Karttunen T, Saarnio J, Nyberg P, Salo T, Graves D, et al. Short DNA sequences and bacterial DNA induce esophageal, gastric, and colorectal cancer cell invasion. APMIS. 2013;121:511-22 pubmed publisher |
| Siponen M, Kauppila J, Soini Y, Salo T. TLR4 and TLR9 are induced in oral lichen planus. J Oral Pathol Med. 2012;41:741-7 pubmed publisher |
| Souza Fonseca Guimaraes F, Parlato M, Fitting C, Cavaillon J, Adib Conquy M. NK cell tolerance to TLR agonists mediated by regulatory T cells after polymicrobial sepsis. J Immunol. 2012;188:5850-8 pubmed publisher |
| Silver A, Arjona A, Walker W, Fikrig E. The circadian clock controls toll-like receptor 9-mediated innate and adaptive immunity. Immunity. 2012;36:251-61 pubmed publisher |
| O Hara J, Feener T, Fischer C, Buret A. Campylobacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice. Infect Immun. 2012;80:1563-71 pubmed publisher |
| Zuo D, Yu X, Guo C, Yi H, Chen X, Conrad D, et al. Molecular chaperoning by glucose-regulated protein 170 in the extracellular milieu promotes macrophage-mediated pathogen sensing and innate immunity. FASEB J. 2012;26:1493-505 pubmed publisher |
| Kauppila J, Takala H, Selander K, Lehenkari P, Saarnio J, Karttunen T. Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma. Histopathology. 2011;59:643-9 pubmed publisher |
| Ronkainen H, Hirvikoski P, Kauppila S, Vuopala K, Paavonen T, Selander K, et al. Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma. J Exp Clin Cancer Res. 2011;30:84 pubmed publisher |
| Luckhardt T, Coomes S, Trujillo G, Stoolman J, Vannella K, Bhan U, et al. TLR9-induced interferon ? is associated with protection from gammaherpesvirus-induced exacerbation of lung fibrosis. Fibrogenesis Tissue Repair. 2011;4:18 pubmed publisher |
| Lundeen J, Sutherland B, Patel A, Stewart C, Bamber C. Direct measurement of the quantum wavefunction. Nature. 2011;474:188-91 pubmed publisher |
| Karim R, Meyers C, Backendorf C, Ludigs K, Offringa R, van Ommen G, et al. Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes. PLoS ONE. 2011;6:e17848 pubmed publisher |
| Dasgupta G, Chentoufi A, You S, Falatoonzadeh P, Urbano L, Akhtarmalik A, et al. Engagement of TLR2 reverses the suppressor function of conjunctiva CD4+CD25+ regulatory T cells and promotes herpes simplex virus epitope-specific CD4+CD25- effector T cell responses. Invest Ophthalmol Vis Sci. 2011;52:3321-33 pubmed publisher |
| van Gent M, Griffin B, Berkhoff E, van Leeuwen D, Boer I, Buisson M, et al. EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection. J Immunol. 2011;186:1694-702 pubmed publisher |
| Myles A, Aggarwal A. Expression of Toll-like receptors 2 and 4 is increased in peripheral blood and synovial fluid monocytes of patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis. Rheumatology (Oxford). 2011;50:481-8 pubmed publisher |
| Baumann C, Aspalter I, Sharif O, Pichlmair A, Blüml S, Grebien F, et al. CD14 is a coreceptor of Toll-like receptors 7 and 9. J Exp Med. 2010;207:2689-701 pubmed publisher |
| Schneberger D, Lewis D, Caldwell S, Singh B. Expression of toll-like receptor 9 in lungs of pigs, dogs and cattle. Int J Exp Pathol. 2011;92:1-7 pubmed publisher |
| Sethi R, Brar R, Singh O, Singh B. Immunolocalization of pulmonary intravascular macrophages, TLR4, TLR9 and IL-8 in normal and Pasteurella multocida-infected lungs of water buffalo (Bubalus bubalis). J Comp Pathol. 2011;144:135-44 pubmed publisher |
| Wang C, Cao S, Yan Y, Ying Q, Jiang T, Xu K, et al. TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients. BMC Cancer. 2010;10:415 pubmed publisher |
| Booth J, Arsenault R, Napper S, Griebel P, Potter A, Babiuk L, et al. TLR9 signaling failure renders Peyer's patch regulatory B cells unresponsive to stimulation with CpG oligodeoxynucleotides. J Innate Immun. 2010;2:483-94 pubmed publisher |
| Keestra A, de Zoete M, Bouwman L, van Putten J. Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9. J Immunol. 2010;185:460-7 pubmed publisher |
| Jukkola Vuorinen A, Rahko E, Vuopala K, Desmond R, Lehenkari P, Harris K, et al. Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer. J Innate Immun. 2009;1:59-68 pubmed publisher |
| Machida H, Ito S, Hirose T, Takeshita F, Oshiro H, Nakamura T, et al. Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis. Nephrol Dial Transplant. 2010;25:2530-537 pubmed publisher |
| Kim Y, Park J, Brand D, Fitzpatrick E, Yi A. Protein kinase D1 is essential for the proinflammatory response induced by hypersensitivity pneumonitis-causing thermophilic actinomycetes Saccharopolyspora rectivirgula. J Immunol. 2010;184:3145-56 pubmed publisher |
| Panda A, Qian F, Mohanty S, van Duin D, Newman F, Zhang L, et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol. 2010;184:2518-27 pubmed publisher |
| Chentoufi A, Dasgupta G, Nesburn A, Bettahi I, Binder N, Choudhury Z, et al. Nasolacrimal duct closure modulates ocular mucosal and systemic CD4(+) T-cell responses induced following topical ocular or intranasal immunization. Clin Vaccine Immunol. 2010;17:342-53 pubmed publisher |
| Väisänen M, Väisänen T, Jukkola Vuorinen A, Vuopala K, Desmond R, Selander K, et al. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors. Prostate. 2010;70:817-24 pubmed publisher |
| Wu J, Meng Z, Jiang M, Zhang E, Trippler M, Broering R, et al. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific. Immunology. 2010;129:363-74 pubmed publisher |
| Schneberger D, Caldwell S, Suri S, Singh B. Expression of toll-like receptor 9 in horse lungs. Anat Rec (Hoboken). 2009;292:1068-77 pubmed publisher |
| Yang X, Fullerton D, Su X, Ao L, Cleveland J, Meng X. Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2. J Am Coll Cardiol. 2009;53:491-500 pubmed publisher |
| Zhou M, McFarland Mancini M, Funk H, Husseinzadeh N, Mounajjed T, Drew A. Toll-like receptor expression in normal ovary and ovarian tumors. Cancer Immunol Immunother. 2009;58:1375-85 pubmed publisher |
| Donaghy H, Bosnjak L, Harman A, Marsden V, Tyring S, Meng T, et al. Role for plasmacytoid dendritic cells in the immune control of recurrent human herpes simplex virus infection. J Virol. 2009;83:1952-61 pubmed publisher |
| Palladino M, Savarese M, Chapman J, Dughi M, Plaska D. Localization of Toll-like receptors on epididymal epithelial cells and spermatozoa. Am J Reprod Immunol. 2008;60:541-55 pubmed publisher |
| Sacre S, Lo A, Gregory B, Simmonds R, Williams L, Feldmann M, et al. Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures. J Immunol. 2008;181:8002-9 pubmed |
| Ilvesaro J, Merrell M, Li L, Wakchoure S, Graves D, Brooks S, et al. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion. Mol Cancer Res. 2008;6:1534-43 pubmed publisher |
| Meneghin A, Choi E, Evanoff H, Kunkel S, Martinez F, Flaherty K, et al. TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation. Histochem Cell Biol. 2008;130:979-92 pubmed publisher |
| Cohen P, Koski G, Czerniecki B, Bunting K, Fu X, Wang Z, et al. STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells. Blood. 2008;112:1832-43 pubmed publisher |
| Selleri S, Palazzo M, Deola S, Wang E, Balsari A, Marincola F, et al. Induction of pro-inflammatory programs in enteroendocrine cells by the Toll-like receptor agonists flagellin and bacterial LPS. Int Immunol. 2008;20:961-70 pubmed publisher |
| Ju X, Zenke M, Hart D, Clark G. CD300a/c regulate type I interferon and TNF-alpha secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands. Blood. 2008;112:1184-94 pubmed publisher |
| Hammadi A, Billard C, Faussat A, Kolb J. Stimulation of iNOS expression and apoptosis resistance in B-cell chronic lymphocytic leukemia (B-CLL) cells through engagement of Toll-like receptor 7 (TLR-7) and NF-kappaB activation. Nitric Oxide. 2008;19:138-45 pubmed publisher |
| Zhang Y, Davis E, Blecha F, Wilkerson M. Molecular cloning and characterization of equine Toll-like receptor 9. Vet Immunol Immunopathol. 2008;124:209-19 pubmed publisher |
| Cognasse F, Hamzeh Cognasse H, Lafarge S, Chavarin P, Pozzetto B, Richard Y, et al. Identification of two subpopulations of purified human blood B cells, CD27- CD23+ and CD27high CD80+, that strongly express cell surface Toll-like receptor 9 and secrete high levels of interleukin-6. Immunology. 2008;125:430-7 pubmed publisher |
| Burgener I, Jungi T. Antibodies specific for human or murine Toll-like receptors detect canine leukocytes by flow cytometry. Vet Immunol Immunopathol. 2008;124:184-91 pubmed publisher |
| Nakamura K, Miyazato A, Xiao G, Hatta M, Inden K, Aoyagi T, et al. Deoxynucleic acids from Cryptococcus neoformans activate myeloid dendritic cells via a TLR9-dependent pathway. J Immunol. 2008;180:4067-74 pubmed |
| Pegu A, Qin S, Fallert Junecko B, Nisato R, Pepper M, Reinhart T. Human lymphatic endothelial cells express multiple functional TLRs. J Immunol. 2008;180:3399-405 pubmed |
| Meng Y, Kujas M, Marie Y, Paris S, Thillet J, Delattre J, et al. Expression of TLR9 within human glioblastoma. J Neurooncol. 2008;88:19-25 pubmed publisher |
| Nakano S, Morimoto S, Suzuki J, Nozawa K, Amano H, Tokano Y, et al. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus. Rheumatology (Oxford). 2008;47:145-9 pubmed |
| Kundu S, Lee C, Billips B, Habermacher G, Zhang Q, Liu V, et al. The toll-like receptor pathway: a novel mechanism of infection-induced carcinogenesis of prostate epithelial cells. Prostate. 2008;68:223-9 pubmed |
| Gonzalez J, Xu H, Ofori E, Elovitz M. Toll-like receptors in the uterus, cervix, and placenta: is pregnancy an immunosuppressed state?. Am J Obstet Gynecol. 2007;197:296.e1-6 pubmed |
| Tran N, Koch A, Berkels R, Boehm O, Zacharowski P, Baumgarten G, et al. Toll-like receptor 9 expression in murine and human adrenal glands and possible implications during inflammation. J Clin Endocrinol Metab. 2007;92:2773-83 pubmed |
| Kindrachuk J, Potter J, Brownlie R, Ficzycz A, Griebel P, Mookherjee N, et al. Nucleic acids exert a sequence-independent cooperative effect on sequence-dependent activation of Toll-like receptor 9. J Biol Chem. 2007;282:13944-53 pubmed |
| Wong C, Cheung P, Ip W, Lam C. Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am J Respir Cell Mol Biol. 2007;37:85-96 pubmed |
| Ewaschuk J, Backer J, Churchill T, Obermeier F, Krause D, Madsen K. Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infect Immun. 2007;75:2572-9 pubmed |
| Palladino M, Johnson T, Gupta R, Chapman J, Ojha P. Members of the Toll-like receptor family of innate immunity pattern-recognition receptors are abundant in the male rat reproductive tract. Biol Reprod. 2007;76:958-64 pubmed |
| Lee J, Mo J, Katakura K, Alkalay I, Rucker A, Liu Y, et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol. 2006;8:1327-36 pubmed |
| Dhara A, Saini M, Das D, Swarup D, Sharma B, Kumar S, et al. Molecular characterization of coding sequences and analysis of Toll-like receptor 3 mRNA expression in water buffalo (Bubalus bubalis) and nilgai (Boselaphus tragocamelus). Immunogenetics. 2007;59:69-76 pubmed publisher |
| Niessner A, Sato K, Chaikof E, Colmegna I, Goronzy J, Weyand C. Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Circulation. 2006;114:2482-9 pubmed |
| Huggins J, Pellegrin T, Felgar R, Wei C, Brown M, Zheng B, et al. CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells. Blood. 2007;109:1611-9 pubmed |
| Wang H, Nicholas M, Conway K, Sen P, Diz R, Tisch R, et al. EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J Immunol. 2006;177:2793-802 pubmed |
| Mansson A, Adner M, Cardell L. Toll-like receptors in cellular subsets of human tonsil T cells: altered expression during recurrent tonsillitis. Respir Res. 2006;7:36 pubmed |
| Gottenberg J, Cagnard N, Lucchesi C, Letourneur F, Mistou S, Lazure T, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proc Natl Acad Sci U S A. 2006;103:2770-5 pubmed |
| Martin Armas M, Simon Santamaria J, Pettersen I, Moens U, Smedsrød B, Sveinbjørnsson B. Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides. J Hepatol. 2006;44:939-46 pubmed |
| Lee J, Wu C, Lee K, Chuang T, Katakura K, Liu Y, et al. Activation of anti-hepatitis C virus responses via Toll-like receptor 7. Proc Natl Acad Sci U S A. 2006;103:1828-33 pubmed |
| Damiano V, Caputo R, Bianco R, D Armiento F, Leonardi A, De Placido S, et al. Novel toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitors. Clin Cancer Res. 2006;12:577-83 pubmed |
| Tabeta K, Hoebe K, Janssen E, Du X, Georgel P, Crozat K, et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat Immunol. 2006;7:156-64 pubmed |
| Srivastava M, Srivastava B. Expression of mRNA and proteins for toll-like receptors, associated molecules, defensins and LL-37 by SRIK-NKL, a CD8+ NK/T cell line. Leuk Res. 2005;29:813-20 pubmed |
| Miller L, Sørensen O, Liu P, Jalian H, Eshtiaghpour D, Behmanesh B, et al. TGF-alpha regulates TLR expression and function on epidermal keratinocytes. J Immunol. 2005;174:6137-43 pubmed |
| Abel K, Wang Y, Fritts L, Sanchez E, Chung E, Fitzgerald Bocarsly P, et al. Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoi. Clin Diagn Lab Immunol. 2005;12:606-21 pubmed |
| Cognasse F, Hamzeh H, Chavarin P, Acquart S, Genin C, Garraud O. Evidence of Toll-like receptor molecules on human platelets. Immunol Cell Biol. 2005;83:196-8 pubmed |
| Greene C, Carroll T, Smith S, Taggart C, Devaney J, Griffin S, et al. TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. J Immunol. 2005;174:1638-46 pubmed |
| Droemann D, Albrecht D, Gerdes J, Ulmer A, Branscheid D, Vollmer E, et al. Human lung cancer cells express functionally active Toll-like receptor 9. Respir Res. 2005;6:1 pubmed |
| Zhong F, Cao W, Chan E, Tay P, Cahya F, Zhang H, et al. Deviation from major codons in the Toll-like receptor genes is associated with low Toll-like receptor expression. Immunology. 2005;114:83-93 pubmed |
| Lee H, Dunzendorfer S, Tobias P. Cytoplasmic domain-mediated dimerizations of toll-like receptor 4 observed by beta-lactamase enzyme fragment complementation. J Biol Chem. 2004;279:10564-74 pubmed |
| Gantner F, Hermann P, Nakashima K, Matsukawa S, Sakai K, Bacon K. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides. Eur J Immunol. 2003;33:1576-85 pubmed |
